Lataa...
Effectiveness and tolerability of transdermal rivastigmine in the treatment of Alzheimer’s disease in daily practice
BACKGROUND: Oral cholinesterase inhibitors at doses efficacious for the treatment of Alzheimer’s disease (AD) are often prematurely discontinued due to gastrointestinal side effects. In controlled clinical trials, transdermal rivastigmine demonstrated less such effects at similar efficacy. The curre...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3333784/ https://ncbi.nlm.nih.gov/pubmed/22536070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S29116 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|